Top compounds associated with response to EIF2S3L


Feature Type Standardized
Nominal ANOVA
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.047 0.1
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.054 0.1
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.05 0.1
mRNA KPT185 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA staurosporine CTRPv2 pan-cancer AAC -0.11 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.1
mRNA narciclasine CTRPv2 pan-cancer AAC -0.048 0.1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.1
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.046 0.1
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.076 0.1
Download CSV